Generali


First take: good signals from the life business

17/11/23 -"The results were in line for Generali, with good signals from the Life business. The impact on life CSM from the revised customer lapse assumption is lower, and the CSM contribution is still strong ..."

Pages
58
Language
English
Published on
17/11/23
You may also be interested by these reports :
04/12/23
Following the 9M23 trading update, our model has been adjusted to reflect the results, which were broadly in line with our projections for top-line ...

01/12/23
Swiss Re announced some new targets at today‚Äôs Investors´ Day. The Group is targeting IFRS net income of more than $3.6bn for 2024 compared with more ...

29/11/23
We have cut our Generali Target Price due to the weaker H2 which was impacted by higher NatCat losses than had been forecast in our previous model. ...

22/11/23
Helvetia has also released a profit warning for H2 23, having estimated the net claims burden from natural catastrophes and major loss events in Q3 ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO